POLYSPECIFIC STEROID AND DRUG TRANSPORT BY AN ORGANIC ANION TRANSPORTER OF HUMAN LIVER

被引:0
|
作者
BOSSUYT, X
SCHROEDER, A
MULLER, M
HAGENBUCH, B
MEIER, PJ
机构
[1] UNIV ZURICH HOSP,DEPT MED,DIV CLIN PHARMACOL & TOXICOL,CH-8091 ZURICH,SWITZERLAND
[2] UNIV GRONINGEN HOSP,DEPT GASTROENTEROL & HEPATOL,GRONINGEN,NETHERLANDS
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:530 / 530
页数:1
相关论文
共 50 条
  • [41] Electrophysiological Characterization of the Polyspecific Organic Cation Transporter Plasma Membrane Monoamine Transporter
    Itagaki, Shiro
    Ganapathy, Vadivel
    Ho, Horace T. B.
    Zhou, Mingyan
    Babu, Ellappan
    Wang, Joanne
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (06) : 1138 - 1143
  • [42] Human Organic Anion Transporter hOAT4 is a Transporter of Perfluorooctanoic Acid
    Nakagawa, Hatsuki
    Terada, Tomohiro
    Harada, Kouji H.
    Hitomi, Toshiaki
    Inoue, Kayoko
    Inui, Ken-ichi
    Koizumi, Akio
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2009, 105 (02) : 136 - 138
  • [43] Human renal organic anion transporter 4 operates as an asymmetric urate transporter
    Hagos, Yohannes
    Stein, Daniel
    Ugele, Bernhard
    Burckhardt, Gerhard
    Bahn, Andrew
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (02): : 430 - 439
  • [44] Rat organic anion transporter 3 and organic anion transporting polypeptide 1 mediate perfluorooctanoic acid transport
    Katakura, Masanori
    Kudo, Naomi
    Tsuda, Tadashi
    Hibino, Yasuhide
    Mitsumoto, Atsushi
    Kawashima, Yoichi
    JOURNAL OF HEALTH SCIENCE, 2007, 53 (01) : 77 - 83
  • [45] Identification of a novel organic anion transporter OAT6 mediating carnitine transport in mouse liver and kidney
    Anzai, N
    Tsuchida, H
    Shin, HJ
    Babu, E
    Jutabha, P
    Sakama, K
    Kanai, Y
    Endou, H
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 281P - 281P
  • [46] Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach
    Mathialagan, Sumathy
    Piotrowski, Mary A.
    Tess, David A.
    Feng, Bo
    Litchfield, John
    Varma, Manthena V.
    DRUG METABOLISM AND DISPOSITION, 2017, 45 (04) : 409 - 417
  • [47] Interactions of selected antivirals with human organic anion transporter 1 in vitro and potential influence of drug competitors
    Mandikova, Jana
    Novy, Zbynek
    Volkova, Marie
    Pavek, Petr
    Trejtnar, Frantisek
    DRUG METABOLISM REVIEWS, 2011, 43 : 203 - 204
  • [48] Characterizing the expression and interindividual variability of organic anion transporter 7 (OAT7) in human liver
    Riedmaier, Emami A.
    van Eijck, B.
    Schaeffeler, E.
    Burk, O.
    Zanger, U.
    Schwab, M.
    Nies, A.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S20 - S20
  • [49] Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules
    Ekaratanawong, S
    Anzai, N
    Jutabha, P
    Miyazaki, H
    Noshiro, R
    Takeda, M
    Kanai, Y
    Sophasan, S
    Endou, H
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 (03) : 297 - 304
  • [50] Substrate specificity in a model of the human organic anion transporter 3
    Perry, Jennifer L.
    Srimaroeng, Chutima
    Dembla-Rajpal, Neetu
    Hall, Laura A.
    Pritchard, John B.
    FASEB JOURNAL, 2007, 21 (06): : A908 - A908